Answers are grounded in this paper and cite their sources.
Thus far, this gene therapy approach has been well tolerated and shows PET evidence of sustained gene expression. These initial findings demonstrate the safety of the therapy; higher doses of adeno-associated viral vector containing the human aromatic l-amino acid decarboxylase gene in the next cohort of patients may further increase dopamine production in the putamen and provide more profound clinical benefit.
No takes yet. Share an insight, caveat, or question.
Eberling et al. (2008) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: